274 related articles for article (PubMed ID: 17400857)
1. C-reactive protein concentrations and subsequent ovarian cancer risk.
McSorley MA; Alberg AJ; Allen DS; Allen NE; Brinton LA; Dorgan JF; Pollak M; Tao Y; Helzlsouer KJ
Obstet Gynecol; 2007 Apr; 109(4):933-41. PubMed ID: 17400857
[TBL] [Abstract][Full Text] [Related]
2. Plasma C-reactive protein and risk of colorectal cancer in a nested case-control study: Japan Public Health Center-based prospective study.
Otani T; Iwasaki M; Sasazuki S; Inoue M; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):690-5. PubMed ID: 16614110
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein and colorectal adenoma in the CLUE II cohort.
Tsilidis KK; Erlinger TP; Rifai N; Hoffman S; Hoffman-Bolton J; Helzlsouer KJ; Platz EA
Cancer Causes Control; 2008 Aug; 19(6):559-67. PubMed ID: 18214695
[TBL] [Abstract][Full Text] [Related]
4. Serum follicle-stimulating hormone and risk of epithelial ovarian cancer in postmenopausal women.
Arslan AA; Zeleniuch-Jacquotte A; Lundin E; Micheli A; Lukanova A; Afanasyeva Y; Lenner P; Krogh V; Muti P; Rinaldi S; Kaaks R; Berrino F; Hallmans G; Toniolo P
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1531-5. PubMed ID: 14693749
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein and risk of breast cancer.
Zhang SM; Lin J; Cook NR; Lee IM; Manson JE; Buring JE; Ridker PM
J Natl Cancer Inst; 2007 Jun; 99(11):890-4. PubMed ID: 17551149
[TBL] [Abstract][Full Text] [Related]
6. No association between pre-diagnostic plasma C-reactive protein concentration and subsequent prostate cancer.
Platz EA; De Marzo AM; Erlinger TP; Rifai N; Visvanathan K; Hoffman SC; Helzlsouer KJ
Prostate; 2004 Jun; 59(4):393-400. PubMed ID: 15065087
[TBL] [Abstract][Full Text] [Related]
7. A prospective study on folate, B12, and pyridoxal 5'-phosphate (B6) and breast cancer.
Wu K; Helzlsouer KJ; Comstock GW; Hoffman SC; Nadeau MR; Selhub J
Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):209-17. PubMed ID: 10090298
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein levels and subsequent cancer outcomes: results from a prospective cohort study.
Helzlsouer KJ; Erlinger TP; Platz EA
Eur J Cancer; 2006 Apr; 42(6):704-7. PubMed ID: 16513341
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study.
Siemes C; Visser LE; Coebergh JW; Splinter TA; Witteman JC; Uitterlinden AG; Hofman A; Pols HA; Stricker BH
J Clin Oncol; 2006 Nov; 24(33):5216-22. PubMed ID: 17114654
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of serum C-reactive protein and colorectal cancer risk in men.
Gunter MJ; Stolzenberg-Solomon R; Cross AJ; Leitzmann MF; Weinstein S; Wood RJ; Virtamo J; Taylor PR; Albanes D; Sinha R
Cancer Res; 2006 Feb; 66(4):2483-7. PubMed ID: 16489056
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of C-reactive protein and serum amyloid A and gastric cancer in a nested case-control study: Japan Public Health Center-based prospective study.
Sasazuki S; Inoue M; Sawada N; Iwasaki M; Shimazu T; Yamaji T; Tsugane S;
Carcinogenesis; 2010 Apr; 31(4):712-8. PubMed ID: 20083644
[TBL] [Abstract][Full Text] [Related]
12. Association of endogenous sex hormone with C-reactive protein levels in middle-aged and elderly men.
Nakhai Pour HR; Grobbee DE; Muller M; van der Schouw YT
Clin Endocrinol (Oxf); 2007 Mar; 66(3):394-8. PubMed ID: 17302874
[TBL] [Abstract][Full Text] [Related]
13. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
14. Plasma C-reactive protein and risk of cancer: a prospective study from Greece.
Trichopoulos D; Psaltopoulou T; Orfanos P; Trichopoulou A; Boffetta P
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):381-4. PubMed ID: 16492932
[TBL] [Abstract][Full Text] [Related]
15. Plasma concentrations of C-reactive protein and total homocysteine in relation to the severity and risk factors for cerebrovascular disease.
Youssef MY; Mojiminiyi OA; Abdella NA
Transl Res; 2007 Sep; 150(3):158-63. PubMed ID: 17761368
[TBL] [Abstract][Full Text] [Related]
16. Circulating visfatin level is correlated with inflammation, but not with insulin resistance.
Oki K; Yamane K; Kamei N; Nojima H; Kohno N
Clin Endocrinol (Oxf); 2007 Nov; 67(5):796-800. PubMed ID: 17634078
[TBL] [Abstract][Full Text] [Related]
17. Serum C-reactive protein does not predict rheumatoid arthritis.
Aho K; Palosuo T; Knekt P; Alha P; Aromaa A; Heliövaara M
J Rheumatol; 2000 May; 27(5):1136-8. PubMed ID: 10813278
[TBL] [Abstract][Full Text] [Related]
18. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk.
Onat A; Can G; Hergenç G
Metabolism; 2008 Feb; 57(2):207-14. PubMed ID: 18191050
[TBL] [Abstract][Full Text] [Related]
19. A prospective study of maternal serum C-reactive protein (CRP) concentrations and risk of gestational diabetes mellitus.
Qiu C; Sorensen TK; Luthy DA; Williams MA
Paediatr Perinat Epidemiol; 2004 Sep; 18(5):377-84. PubMed ID: 15367325
[TBL] [Abstract][Full Text] [Related]
20. Frequency of elevation of C-reactive protein in atrial fibrillation.
Anderson JL; Allen Maycock CA; Lappé DL; Crandall BG; Horne BD; Bair TL; Morris SR; Li Q; Muhlestein JB;
Am J Cardiol; 2004 Nov; 94(10):1255-9. PubMed ID: 15541240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
